Ryan D. Maynard
2015
In 2015, Ryan D. Maynard earned a total compensation of $1.1M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $187,571 |
|---|---|
| Option Awards | $476,735 |
| Salary | $441,345 |
| Other | $1,170 |
| Total | $1,106,821 |
Maynard received $476.7K in option awards, accounting for 43% of the total pay in 2015.
Maynard also received $187.6K in non-equity incentive plan, $441.3K in salary and $1.2K in other compensation.
Rankings
In 2015, Ryan D. Maynard's compensation ranked 7,457th out of 13,638 executives tracked by ExecPay. In other words, Maynard earned more than 45.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,457 out of 13,638 | 45th |
Division Manufacturing | 2,813 out of 5,187 | 46th |
Major group Chemicals And Allied Products | 1,020 out of 1,857 | 45th |
Industry group Drugs | 822 out of 1,531 | 46th |
Industry Pharmaceutical Preparations | 643 out of 1,179 | 46th |
Source: SEC filing on March 29, 2017.
Maynard's colleagues
We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2015.